Blockade of Interleukin-6 Receptor with Tocilizumab During the AcutePhase of Childhood Immune-Mediated Epilepsy can Lead to a FavorableOutcome - an Observational Study

Tocilizumab is effective for the management of immune-mediated epilepsy in children when given early enough.

Authors

Institutions

Publication Details

Journal
Current Neuropharmacology
Published
2026-01-15
DOI
https://doi.org/10.2174/011570159x455475251203194508
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blockade of Interleukin-6 Receptor with Tocilizumab During the AcutePhase of Childhood Immune-Mediated Epilepsy can Lead to a FavorableOutcome - an Observational Study

Zhanwei Zhang, Miriam Kessi, Jielu Tan, Xiaolu Deng et al.
Current Neuropharmacology
Epilepsy research and treatment
article

Blockade of Interleukin-6 Receptor with Tocilizumab During the AcutePhase of Childhood Immune-Mediated Epilepsy can Lead to a FavorableOutcome - an Observational Study

Zhanwei Zhang, Miriam Kessi, Jielu Tan, Xiaolu Deng, Ciliu Zhang, Fei Yin, Lifen Yang, Jing Peng, Fang He
article en

Abstract

Tocilizumab is effective for the management of immune-mediated epilepsy in children when given early enough.

Current NeuropharmacologyVol. 24
Central South University (CN), Education Department of Hunan Province (CN), Xiangya Hospital Central South University (CN)
Good health and well-being
Openalex Percentile: Top 78%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.